CardioNETPOL
Not yet recruiting
120 enrolled
NOECHO
Enrolling by invitation
50 enrolled
SCPC
Completed
100 enrolled
TRPC6 Characterization to Predict and Prevent Chemotherapy Related Cardiomyopathy and Heart Failure With Breast Cancer
Recruiting
200 enrolled
BREACH-fMRI
Recruiting
16 enrolled
Symptom Burden and Health Related Quality of Life of Cancer Patients With Concurrent Heart Failure
Recruiting
100 enrolled
PAtient Similarity for Decision-Making in Prevention of Cardiovascular Toxicity (PACT): A Feasibility Study
Not yet recruiting
60 enrolled
ML-CardioTox
Not yet recruiting
600 enrolled
CLARITY
Completed
217 enrolled
Patient Reported Unmet Needs for Function and Supportive Occupational- and Physiotherapy Rehabilitation Interventions
Completed
43 enrolled
Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)
Completed
1,149 enrolled
Cardiovascular Multimodality Imaging Study
Recruiting
5,000 enrolled
Identification of Anticancer Drugs Associated With Cancer Therapy-related Cardiac Dysfunction: a Pharmacovigilance Study
Completed
36,580,288 enrolled
CATCH-HF
Recruiting
150 enrolled
Semmelweis Esophageal Cancer Study: Noninvasive Prognostic Parameters in Patients With Oesophageal and Esophagogastric Junction Cancer
Recruiting
100 enrolled
Comparing the Diagnostic Sensitivity and Specificity of Pleural Fluid N-Terminal Pro B-type Natriuretic Peptide (NT-proBNP) and Other Biochemical Gradient Criteria in Distinguishing Heart Failure and Non-heart Failure Related Pleural Effusions (CENTRE Study)
Recruiting
120 enrolled
QUANTUM
Enrolling by invitation
3,000 enrolled
Emulation of the Moderate Alcohol and Cardiovascular Health Trial (MACH15)
Completed
503,325 enrolled
Multi-mobility
Not yet recruiting
55 enrolled
BLOC-II
Recruiting
455 enrolled
FATIGUE
Unknown
40 enrolled
PatientSpot Formerly Known as ArthritisPower
Unknown
40,000 enrolled
LTC
Unknown
600 enrolled
PTN_POPS
Completed
3,520 enrolled
UCARE
Recruiting
100 enrolled
CASPER
Completed
54 enrolled
CARES
Completed
744 enrolled
NEOCARDIO
Unknown
5,000 enrolled
A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mg
Completed
1,149 enrolled
A Study of Special Use Results Surveillance of Revlimid 5mg Capsules
Completed
4,626 enrolled
A Safety and Efficacy Study of Revlimid® 5 mg Capsules in Patients With Relapsed or Refractory Multiple Myeloma Who Have Received Long-term Treatment With it Under the Actual Condition of Use
Completed
361 enrolled
Identification of Novel Inflammation-related Biomarkers for Early Detection of Anthracycline-induced Cardiotoxicity in Breast Cancer Patients
Unknown
180 enrolled
Evaluation and Management of Cardio Toxicity in Oncologic Patients
Recruiting
1,000 enrolled
SELF - BREATHE for Chronic Breathlessness
Completed
25 enrolled
The Role of suPAR Biomarker in Blood Samples of Breast Cancer Patients During and Post Doxorubicin Chemotherapy: Causative vs. Predictor
Completed
42 enrolled
Personalized Experiences to Inform Improved Communication for Minorities With Life Limiting Illness
Completed
38 enrolled 9 charts
ACCEPT
Completed
503 enrolled
Early Detection of Heart Problems in Cancer Patients Receiving Chemotherapy
Withdrawn
COMO-GMC
Completed
5,940,299 enrolled
Cardiomyopathy Tissue Bank in a Cancer Population
Unknown
1,000 enrolled
Novel Biomarkers and Echocardiography for Subclinical Cardiac Toxicity in Breast Cancer Patients Receiving Anthracyclines
Unknown
35 enrolled
CaTOB
Completed
45 enrolled
Early Detection of Cardiac Toxicity in Childhood Cancer Survivors
Terminated
42 enrolled
ARBITRAGE
Completed
1,717 enrolled
OXYPAL
Unknown
330 enrolled
CCHS
Completed
23,891 enrolled
Early Assessment of Anthracycline-induced Cardiotoxicity (CARDIOTOX)
Terminated
6 enrolled
Epidemiology of Cardiotoxicity in Children With Cancer
Completed
Metabolic Changes in Patients With Chronic Cardiopulmonary Disease
Unknown
400 enrolled
CATS
Completed
220 enrolled